SCYNEXIS, Inc. (SCYX)
NASDAQ: SCYX · Real-Time Price · USD
4.450
+0.340 (8.27%)
Sep 17, 2026, 4:00 PM EDT - Market closed
SCYNEXIS Employees
SCYNEXIS had 18 employees as of December 31, 2025. The number of employees decreased by 10 or -35.71% compared to the previous year.
Employees
18
Change (1Y)
-10
Growth (1Y)
-35.71%
Revenue / Employee
$1,067,556
Profits / Employee
-$568,611
Market Cap
44.28M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 18 | -10 | -35.71% |
| Dec 31, 2024 | 28 | -1 | -3.45% |
| Dec 31, 2023 | 29 | -7 | -19.44% |
| Dec 31, 2022 | 36 | -20 | -35.71% |
| Dec 31, 2021 | 56 | 18 | 47.37% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| InterCure | 285 |
| Zhengye Biotechnology Holding | 269 |
| Universe Pharmaceuticals INC | 216 |
| China Pharma Holdings | 215 |
| Rockwell Medical | 157 |
| Aytu BioPharma | 83 |
| Incannex Healthcare | 12 |
| Talphera | 12 |
SCYX News
- 2 days ago - SCYNEXIS Appoints Todd Minga, M.D., as Senior Vice President, Research & Development - GlobeNewsWire
- 6 days ago - SCYNEXIS Transcript: 12th Annual Cantor Fitzgerald Global Healthcare Conference - Transcripts
- 7 days ago - Scynexis CFO Ivor Macleod retires, Sanjay Subramanian succeeds - TheFly
- 7 days ago - SCYNEXIS Announces Appointment of Sanjay Subramanian as Chief Financial Officer - GlobeNewsWire
- 16 days ago - SCYNEXIS to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 23 days ago - SCYNEXIS Announces Inducement Award Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 4 weeks ago - Scynexis price target raised to $33 from $24 at Guggenheim - TheFly
- 5 weeks ago - Scynexis reports Q2 EPS 63c, consensus (51c) - TheFly